Skip to main content
SpringerLink
Log in

First-in-human 18F-SiFAlin-TATE PET/CT for NET imaging and theranostics

  • Image of the Month
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bodei L, Mueller-Brand J, Baum RP, Pavel ME, Horsch D, O’Dorisio MS, et al. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2013;40:800–16. https://doi.org/10.1007/s00259-012-2330-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Pavel M, O’Toole D, Costa F, Capdevila J, Gross D, Kianmanesh R, et al. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology. 2016;103:172–85. https://doi.org/10.1159/000443167.

    Article  CAS  PubMed  Google Scholar 

  3. Niedermoser S, Chin J, Wangler C, Kostikov A, Bernard-Gauthier V, Vogler N, et al. In vivo evaluation of (1)(8)F-SiFAlin-modified TATE: a potential challenge for (6)(8)Ga-DOTATATE, the clinical gold standard for somatostatin receptor imaging with PET. J Nucl Med. 2015;56:1100–5. https://doi.org/10.2967/jnumed.114.149583.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, University Hospital of Munich, Munich, Germany

    Harun Ilhan, A. Todica, S. Lindner, G. Boening, A. Gosewisch & P. Bartenstein

  2. Biomedical Chemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany

    C. Wängler

  3. Molecular Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany

    B. Wängler

  4. Department of Oncology, Division of Oncological Imaging, University of Alberta, Edmonton, Alberta, Canada

    R. Schirrmacher

Authors
  1. Harun Ilhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Todica
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Lindner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Boening
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Gosewisch
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C. Wängler
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. B. Wängler
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. Schirrmacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. Bartenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Harun Ilhan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Written informed consent was obtained from the patient.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Image of the month

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ilhan, H., Todica, A., Lindner, S. et al. First-in-human 18F-SiFAlin-TATE PET/CT for NET imaging and theranostics. Eur J Nucl Med Mol Imaging 46, 2400–2401 (2019). https://doi.org/10.1007/s00259-019-04448-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-019-04448-8

Search

Navigation